Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $21.18B | $20B | +5.91% |
Cost of Revenue | $4.67B | $4.41B | +5.94% |
Operating Income | $-790M | $5.99B | -113.18% |
Net Income | $-1.3B | $4.24B | -130.76% |
EPS (Basic) | $-1.04 | $3.39 | -130.68% |
EPS (Diluted) | $-1.04 | $3.37 | -130.86% |
SG&A Expense | $4.18B | $4.48B | -6.65% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $54.52B | $62.37B | -12.58% |
Current Assets | $14.78B | $15.98B | -7.52% |
Current Liabilities | $11.72B | $11.95B | -1.84% |
Stockholders' Equity | $18.48B | $22.31B | -17.20% |
Long-Term Debt | $23.25B | $24.98B | -6.94% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $7.85B | $5.84B | +34.54% |
Investing Cash Flow | $-3.22B | $-1.54B | -109.62% |
Financing Cash Flow | $-5.69B | $-4.03B | -41.41% |
Dividends Paid | $2.94B | $2.87B | +2.76% |
Share Buybacks | $800M | $850M | -5.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -3.7% | 30.0% | -33.69% |
Net Margin | -6.2% | — | — |
ROE | -7.1% | — | — |
ROA | -2.4% | — | — |
Current Ratio | $1.26 | — | — |
Other companies in Biotechnology